One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful ...

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL)—a biomarker of neuronal damage—levels in spinal fluid were lower in ...

An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

However, in late September 2025, scientists successfully treated Huntington’s for the first time in a ground-breaking study.

Families are elated by news of the first treatment for Huntington's disease - but when and how will the NHS fund it?

Huntington’s disease is a brain disorder that can affect various functions, including the ability to swallow — particularly as the disease progresses. Huntington’s disease is a neurogenerative ...

Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only ...

While Huntington’s disease is progressive and worsens over time, understanding what is to come can help someone with this condition plan for the road ahead. Huntington’s disease is a neurodegenerative ...

UniQure's therapy, called AMT-130, reduced disease progression by 75% at 36 months in patients who received a high dose.

TAMPA, Fla. (WFLA) — For the first time, scientists have successfully treated someone suffering from Huntington’s disease, a fatal genetic illness with no cure. The Mayo Clinic reports that the ...

Gene therapy is becoming a powerful way to treat challenging diseases that don’t respond to traditional treatments, and researchers now report the first success in modifying genes to slow Huntington’s ...

Sex influences how genetic and age-related factors translate into clinical and neuroimaging trajectories in Huntington disease.